Analyst Ranking
Bottom 21%
#3957 out of 4939 analysts
Average Return
-0.17%
Win Rate
42%33 out of 78
Risk vs Reward
Poor
Good

Evan Seigerman's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Disc Medicine IncIRON
+165.37%$22.84$60.61
2023-03-23 -
2024-03-22
Buy
Eli Lilly & CoLLY
+71.55%$428.44$734.97
2023-05-04 -
2024-05-03
Buy
Structure Therapeutics IncGPCR
+69.29%$25.56$43.27
2023-02-28 -
2024-02-28
Buy
Eli Lilly & CoLLY
+60.64%$526.23$845.31
2023-08-09 -
2024-08-08
Buy
Gilead Sciences IncGILD
+52.17%$73.66$112.09
2024-08-09 -
2025-07-14
Buy

Evan Seigerman's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Disc Medicine IncIRON
5Buy$120.00+107.83%Maintains
2 months ago
Neurocrine Biosciences IncNBIX
11Hold$115.00-14.90%Maintains
2 months ago
Gilead Sciences IncGILD
13Buy$120.00+7.06%Maintains
3 months ago
Biogen IncBIIB
15Hold$139.00+4.42%Maintains
5 months ago
Vertex Pharmaceuticals IncVRTX
13Buy$545.00+15.38%Maintains
5 months ago
Bristol Myers Squibb CoBMY
11Hold$61.00+28.86%Maintains
8 months ago
Incyte CorpINCY
8Sell$52.00-25.69%Reiterates
9 months ago
Eli Lilly & CoLLY
8Buy$1,101.00+37.74%Maintains
a year ago
Structure Therapeutics IncGPCR
1Buy$40.00N/AInitiates Coverage On
2 years ago
Mirati Therapeutics IncMRTX
4Hold$59.00N/ADowngrades
3 years ago
Replimune Group IncREPL
1Buy$40.00N/AMaintains
3 years ago
Regeneron Pharmaceuticals IncREGN
9Buy$788.00N/AMaintains
3 years ago
Nuvation Bio IncNUVB
2Hold$2.50N/ADowngrades
3 years ago
Candel Therapeutics IncCADL
2Buy$12.00N/AMaintains
3 years ago
Pfizer IncPFE
1Buy$60.00N/AInitiates Coverage On
4 years ago
Amgen IncAMGN
4Hold$228.00N/AInitiates Coverage On
4 years ago
Ikena Oncology IncIKNA
1Buy$30.00N/AInitiates Coverage On
4 years ago
Satsuma Pharmaceuticals IncSTSA
2Hold$6.50N/AUpgrades
4 years ago
Galera Therapeutics IncGRTX
2Buy$15.00N/AUpgrades
5 years ago
Aimmune Therapeutics IncAIMT
3Hold$34.50N/AMaintains
5 years ago
Talphera IncTLPH
5Sell$16.80N/AMaintains
5 years ago
Macrogenics IncMGNX
1Buy$13.00N/AMaintains
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.